In the wake of Puma Biotechnology, Inc.'s (NASDAQ:PBYI) latest US$17m market cap drop, institutional owners may be forced to take severe actions - Simply Wall St News
Puma Biotechnology (NASDAQ:PBYI) investors are sitting on a loss of 86% if they invested five years ago | Nasdaq
![Puma Biotech Stock Struggles To Find Its Footing In Crowded Oncology Space (NASDAQ:PBYI) | Seeking Alpha Puma Biotech Stock Struggles To Find Its Footing In Crowded Oncology Space (NASDAQ:PBYI) | Seeking Alpha](https://static.seekingalpha.com/uploads/2021/4/25/saupload_zys-A0tTqP8PWlrKLGfU8XarhV75bml0GYT6UZXNdTCeU2AaCXx_644abKUiyEdFCXTOTLutlWDqvkveyTHWK0PYMs5db5WuIcg_P_sz1aH9ATSAfg5L9AuFRgTc-G3-cE9vOVv7.png)
Puma Biotech Stock Struggles To Find Its Footing In Crowded Oncology Space (NASDAQ:PBYI) | Seeking Alpha
![Puma Biotechnology | $PBYI Stock | Shares Climb Up as Company Announced FDA Approval for NERLYNX - Warrior Trading News Puma Biotechnology | $PBYI Stock | Shares Climb Up as Company Announced FDA Approval for NERLYNX - Warrior Trading News](https://cdn-news.warriortrading.com/wp-content/uploads/2017/07/19181629/PMYI.jpg)
Puma Biotechnology | $PBYI Stock | Shares Climb Up as Company Announced FDA Approval for NERLYNX - Warrior Trading News
In the wake of Puma Biotechnology, Inc.'s (NASDAQ:PBYI) latest US$17m market cap drop, institutional owners may be forced to take severe actions - Simply Wall St News
![Biotech Stock Mailbag: Puma's Rebound Explained, TG Therapeutics Approval Debate, Aurinia Next Steps - TheStreet Biotech Stock Mailbag: Puma's Rebound Explained, TG Therapeutics Approval Debate, Aurinia Next Steps - TheStreet](https://www.thestreet.com/.image/ar_16:9%2Cc_fill%2Ccs_srgb%2Cfl_progressive%2Cq_auto:good%2Cw_1200/MTY4NjQ3NTYyOTIwNjY2NzU5/biotech-stock-mailbag-trump-aurinia-immunomedics-cellceutix.jpg)
Biotech Stock Mailbag: Puma's Rebound Explained, TG Therapeutics Approval Debate, Aurinia Next Steps - TheStreet
![Puma Biotechnology Stock Forecast: down to 0.000000000016 USD? - PBYI Stock Price Prediction, Long-Term & Short-Term Share Revenue Prognosis with Smart Technical Analysis Puma Biotechnology Stock Forecast: down to 0.000000000016 USD? - PBYI Stock Price Prediction, Long-Term & Short-Term Share Revenue Prognosis with Smart Technical Analysis](https://walletinvestor.b-cdn.net/static/frontend/forecast-graphs/cc/stock-pbyi-stock-forecast.png?v=1643066811)